BDBM733510 (2S,4R)-1-[(2S)-2-{5-[4-(4-amino-3-{4- ethanesulfonamido-3-[(4- fluorophenyl)methoxy]phenyl}-1H- pyrazolo[4,3-c]pyridin-7-yl)-1H-pyrazol-1- yl]pentanamido}-3,3-dimethylbutanoyl]-4- hydroxy-N-{[4-(4-methyl-1,3-thiazol-5- yl)phenyl]methyl}pyrrolidine-2-carboxamide From Intermediate F2. LCMS (method D): 1.80 min, m/z: 510.8 [M + 2H]2+.::US20250115598, Compound 1002

SMILES CCS(=O)(=O)Nc1ccc(-c2nn(C)c3c(-c4cnn(CCCCC(=O)N[C@H](C(=O)N5C[C@H](O)C[C@H]5C(=O)NCc5ccc(-c6scnc6C)cc5)C(C)(C)C)c4)cnc(N)c23)cc1OCc1ccc(F)cc1

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 733510   

TargetMixed lineage kinase domain-like protein(Human)
Anaxis Pharma

US Patent
LigandPNGBDBM733510((2S,4R)-1-[(2S)-2-{5-[4-(4-amino-3-{4- ethanesulfo...)
Affinity DataKd: <50nMAssay Description:Binding affinity of the test compounds for human MLKL (full length), mouse MLKL (full length), human RIPK1 and human RIPK3 was determined using the K...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/22/2025
Entry Details
US Patent